Condition: Congenital Adrenal Hyperplasia · Classic Congenital Adrenal Hyperplasia · Sponsor: Crinetics Pharmaceuticals Inc.
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).
This description comes directly from the study's public registry record.
Crinetics Clinical Trials · 833-827-9741 · clinicaltrials@crinetics.com
Always discuss trial participation with your own doctor first.
| UCSF Ron Conway Gateway Medical Building | San Francisco, California, United States | Recruiting |
| Boston's Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Rutgers Robert Wood Johnson Medical School | New Brunswick, New Jersey, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai-Mount Sinai Hospital | New York, New York, United States | Recruiting |
| Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Cook Children's Health Care System | Fort Worth, Texas, United States | Recruiting |
| University of Virginia Health System | Charlottesville, Virginia, United States | Recruiting |
| Instituto de Investigaciones Metabólicas | Buenos Aires, Buenos Aires, Argentina | Recruiting |
| Hospital de Niños de la Santísima Trinidad | Córdoba, Córdoba Province, Argentina | Recruiting |
| Hospital Italiano de Buenos Aires | Buenos Aires, Argentina | Recruiting |
+ 31 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07159841